PTO/SB/14 (11-08)
`Approved for use through 06/30/2010. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE ~
`Under the Paperwork Reduction Act of 1995, no persons are required to respondto a collection of information unless it contains a valid OMB control number.
`
`Attorney Docket Number|38938-718.101
`Application Data Sheet 37 CFR 1.76
`—
`
`beprinted and included in a paperfiled application.
`
`Title of Invention
`
`METHODS AND COMPOSITIONS FOR DETERMINING NUCLEIC ACID FRAGMENTATION
`
`The application data sheetis part of the provisional or nonprovisional application for whichit is being submitted. The following form contains the
`bibliographic data arrangedin a format specified by the United States Patent and Trademark Office as outlined in 37 CFR 1.76.
`This document may be completed electronically and submitted to the Office in electronic format using the Electronic Filing System (EFS) or the
`document may
`
`Secrecy Order 37 CFR 5.2
`
`Portions or all of the application associated with this Application Data Sheet may fall under a Secrecy Order pursuantto 37 CFR 5.2 (Paperfilers only. Applications that fall under Secrecy Order may notbefiled electronically.)
`
`Applicant Information:
`
`
`
`Applicant Authority @ Inventor|CLegal Representative under 35 U.S.C. 117 C©pParty of Interest under 35 U.S.C. 118
`
`(©) Active US Military Service
`(© NonUSResidency
`ResidenceInformation (Select One) @ US Residency
`
`City|San Mateo State/Province Country of Residencd US
`
`
`Citizenship under 37 CFR 1.41(b}
`US
`Mailing Address of Applicant:
`Address1
`10 De Anza Court
`
`Address 2
`
`City
`
`San Mateo
`
`Postal Code
`
`State/Province
`
`CA
`
`Applicant Authority @JInventor|C)Legal Representative under 35 U.S.C. 117 ©pParty ofInterest under 35 U.S.C. 118
`
`Prefix) Given Name
`Middle Name
`Family Name
`Suffix
`
`Benjamin
`
`
`
`ResidenceInformation (Select One) @ US Residency (©>NonUS Residency (©) Active US Military Service
`
`Citizenship under 37 CFR 1.41(b}
`Mailing Address of Applicant:
`Address 1
`1039 BannockStreet
`
`AU
`
`Address 2
`
`City
`
`Livermore
`
`Postal Code
`
`94551
`
`State/Province
`
`US
`
`
`
`
`
`CA
`
`Applicant Authority © !nventor|(Legal Representative under 35 U.S.C. 117 OPartyof interest under 35 U.S.C. 118
`
`Prefix) Given Name
`Middle Name
`Family Name
`Suffix! -
`
`ResidenceInformation (Select One) @) US Residency
`State/Province
`
`(©) Active US Military Service
`(© NonUS Residency
`Country of Residencé
`US
`
`EFS Web 2.2.2
`
`
`
`

`

`PTO/SB/14 (11-08)
`Approved for use through 06/30/2010. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number,
`
`
`
`Attorney Docket Number|38938-718.101
`Application Data Sheet 37 CFR 1.76
`—~
`
`
`
`
` Title of Invention
`METHODS AND COMPOSITIONS FOR DETERMINING NUCLEIC ACID FRAGMENTATION
`Citizenship under 37 CFR 1.41(b)
`US
`Mailing Address of Applicant:
`Address1
`9981 Torreon Avenue
`
`Address 2
`
`Inventor Information blocks may be
`Inventors Must Be Listed - Additional
`All
`generated within this form by selecting the Add button.
`
`CorrespondenceInformation:
`Enter either Customer Numberor complete the CorrespondenceInformation section below.
`For further information see 37 CFR 1.33(a).
`
`[_] An Addressis being provided for the correspondenceInformation of this application.
`
`Customer Number
`
`21971
`
`Email Address
`
`dprouty@wsgr.com
`
`
`S
`E
`
`Application Information:
`
`
`
`
`
`Title of the Invention
`Attorney Docket Number}
`Application Type
`
`METHODS AND COMPOSITIONS FOR DETERMINING NUCLEIC ACID FRAGMENTATION
`38938-718.101
`Small Entity Status Claimed
`[|]
`
`Provisional
`
`Subject Matter
`Suggested Class(if any)
`
`Utility
`
`Total Numberof Drawing Sheets(if any)
`Publication Information:
`
`Sub Class(if anyPo
`
`Suggested Figure for Publication (if any)
`
`[-] Request Early Publication (Fee required at time of Request 37 CFR 1.219)
`
`
`Request Not to Publish. | hereby request that the attached application not be published under 35
`
`Cl U.S.C. 122(b) and certify that the invention disclosed in the attached application has not and will notbe the
`
`subject of an applicationfiled in another country, or under a multilateral international agreement, that requires
`publication at eighteen monthsafterfiling.
`
`
`
`Representative Information:
`
`
`
`Representative information should be providedfor all practitioners having a powerof attorney in the application. Providing
`this information in the Application Data Sheet does not constitute a power of attorney in the application (see 37 CFR 1.32).
`
`
`Enter either Customer Number or complete the Representative Name section below.If both sections
`are completed the Customer Number will be used for the Representative Information during processing.
`
`
`
`
`Please Select One:
`
`EFS Web 2.2.2
`
`@ Customer Number
`
`©) US PatentPractitioner
`
`
`
`

`

`PTO/SB/14 (11-08)
`Approved for use through 06/30/2010. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respondto a collection of information unless it contains a valid OMB control number.
`
`- gs Attorney Docket Number|38938-718.101
`
`Application Data Sheet 37 CFR 1.76
`——
`Application Number
`
`
`
`
`
`METHODS AND COMPOSITIONS FOR DETERMINING NUCLEIC ACID FRAGMENTATION
`
`
`
`021971
`
`
`
`
`
`
`Title of Invention
`
`Customer Number
`
`Domestic Benefit/National Stage Information:
` This section allows for the applicant to either claim benefit under 35 U.S.C. 119(e), 120, 121, or 365(c) or indicate National Stage
`entry from a PCTapplication. Providing this information in the application data sheet constitutes the specific reference required by
`35 U.S.C. 119(e) or 120, and 37 CFR 1.78(a)(2) or CFR 1.78(a)(4), and need not otherwise be made part of the specification.
`
`
`Prior Application Status
`
`
`
`
`
`Application Number
`
`
`
`Additional Domestic Benefit/National Stage Data may be generated within this form
`by selecting the Add button.
`
`Continuity Type
`
`Prior Application Number
`
`Filing Date (YYYY-MM-DD)
`
`Foreign Priority Information:
`
`
`
`
`
`
`This section allows for the applicant to claim benefit of foreign priority and to identify any prior foreign application for which priority is
`not claimed. Providing this information in the application data sheet constitutes the claim for priority as required by 35 U.S.C. 119(b)
`and 37 CFR 1.55(a).
`|
`
`
`
`ParentFiling Date (YYYY-MM-DD)
`Application Number
`
`
`Additional Foreign Priority Data may be generated within this form by selecting the
`Add button.
`
`
`
`
`© Yes @ No
`
`
`Ef
`
`Priority Claimed
`
` Assignee1
`
`Assignee Information:
`Providing this information in the application data sheet does not substitute for compliance with any requirementof part 3 of Title 37
`of the CFR to have an assignment recorded in the Office.
`
`If the Assignee is an Organization check here.
`
`[x]
`
`Organization Name
`
`Mailing Address Information:
`
`Address1
`
`Address 2
`
`City
`Country!
`
`Us
`
`Email Address
`
`7068 Koll Center Pkwy, Ste 401
`
`Pleasanton
`
`State/Province
`Postal Code
`
`CA
`94566
`
`Additional Assignee Data may be generated within this form by selecting the Add
`button.
`
`Signature:
`A signature of the applicant or representative is required in accordance with 37 CFR 1.33 and 10.18. Please see 37
`CFR 1.4(d) for the form of the signature.
`
`
`
`
`
`EFS Web 2.2.2
`
`

`

`PTO/SB/14 (11-08)
`Approved for use through 06/30/2010. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information uniessit contains a valid OMB control number.
`
`
`
`
`Application Data Sheet 37 CFR 1.76
`
`
`Title of Invention
`METHODS AND COMPOSITIONS FOR DETERMINING NUCLEIC ACID FRAGMENTATION
`
`
`
`
`
`,~4f, fh
`
`
`
`
`
`
`
`This collection of information is required by 37 CFR 1.76. The information is required to obtain or retain a benefit by the public which
`is to file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This
`collection is estimated to take 23 minutes to complete, including gathering, preparing, and submitting the completed application data
`sheet form to the USPTO. Timewill vary depending upon the individual case. Any comments on the amountof time you require to
`complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
`Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR
`COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`EFS Web 2.2.2
`
`

`

`Privacy Act Statement
`
`
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1.
`
`The information onthis form will be treated confidentially to the extent allowed under the Freedom of Information Act (5.U.S.C. 552) and the
`Privacy Act (5 U.S.C, 552a). Records from this system of records may be disclosed to the Departmentof Justice to determine whetherthe
`Freedom of Information Act requires disclosure of these records.
`
`2. Arecord from this system of records may be disclosed, as a routine use, in the course of presenting evidence to a court, magistrate, or
`administrative tribunal, including disclosures to opposing counselin the course of settlement negotiations.
`
`
`
`
`
`
`3.
`
`4.
`
`Arrecord in this system of records maybedisclosed, as a routine use, to a Member of Congress submitting a requestinvolving an individual,
`to whom the record pertains, whenthe individual has requested assistance from the Memberwith respect to the subject matter of the record.
`
` Arecord in this system of records may be disclosed, as a routine use, to a contractor of the Agency having needforthe informationin order
`to perform a contract. Recipients of information shall be required to comply with the requirements of the Privacy Act of 1974, as amended,
`pursuant to 5 U.S.C. 552a(m).
`
`5. Arecord related to an International Application filed under the Patent Cooperation Treatyin this system of records may be disclosed, as a
`routine use, to the International Bureau of the World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submissionof the attached form related to
`a patentapplication or patent. Accordingly, pursuant to the requirements of the Act, please be advised that:
`(1) the general authority for the collection
`of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary; and (3) the principal purpose for which the informationis
`used by the U.S. Patent and Trademark Office is to process and/or examine your submission related to a patent application or patent.
`!f you do not
`furnish the requested information, the U.S. Patent and Trademark Office may not be able to process and/or examine your submission, which may
`result in termination of proceedings or abandonmentof the application or expiration of the patent.
`
`
`becomesawareof a violation or potential violation of law or regulation.
`
`6. Arecord in this system of records may be disclosed, as a routine use, to anotherfederal agency for purposes of National Security review (35
`U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).
`
`7. Arecord from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or his/her designee, during
`an inspection of records conducted by GSA aspart of that agency's responsibility to recommend improvements in records management
`practices and programs, underauthority of 44 U.S.C. 2904 and 2906. Such disclosure shall be made in accordance with the GSA
`regulations governing inspection of records for this purpose, and any other relevant(i.e., GSA or Commerce)directive. Such disclosure
`shall not be used to make determinations aboutindividuals.
`
`
`
`
`8. Arecord from this system of records may be disclosed, as a routine use, to the public after either publication of the application pursuantto
`
`35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37 CFR
`1.14, as a routine use, to the public if the record wasfiled in an application which became abandonedorin which the proceedings were
`terminated and which application is referenced by either a published application, an application open to public inspections or an issued
`patent.
`
`9. Arecord from this system of records may be disclosed, as a routine use, to a Federal, State, or local law enforcement agency, if the USPTO
`
`
`EFS Web 2.2.2
`
`